Filter
285
Text search:
National
Tuberculosis
Programme
(NTP)
Featured
24
102
Language
Document type
249
13
9
7
6
1
Countries / Regions
26
18
15
15
15
14
13
11
8
7
6
5
5
5
4
4
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
115
18
10
5
3
3
2
Toolboxes
181
18
9
5
2
2
2
1
1
1
National Tuberculosis Programme (NTP) is functioning with Regional/State TB centers and 101 vert
...
Framework for implementation.
The END TB Strategy.
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after fai
...
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of malaria, t
...
Tropical Medicine and International Health volume 21 no 1 pp 101-107 january 2016
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not
...
A rapid situation analysis in three districts
Global Plan to end TB 2016-2020
Essential Medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy, safety and comparative cost-effectiveness. This edition of the Essential Medicines List (EML) 2017 for Ghana has been deriv
...
Journal of the International AIDS Society 2017, 20(Suppl 4):21644
National AIDS Programme in Myanmar has made significant progress in scaling up antiretroviral treatment (ART) services and reco ...
National AIDS Programme in Myanmar has made significant progress in scaling up antiretroviral treatment (ART) services and reco ...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra
...
